Sulfadoxine/Pyrimethamine Intermittent Preventive Treatment for Malaria during Pregnancy
Authors:
- Philippe DeloronPDPhilippe Deloron
- Gwladys BertinGBGwladys Bertin
- Valérie BriandVBValérie Briand
- Achille MassougbodjiAMAchille Massougbodji
- Michel CotMCMichel Cot
Open Access
- 1 November 2010
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 16 (11) , 1666-1670
Abstract
For monitoring efficacy of sulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancy, data obtained from studies of children seemed inadequate. High prevalence of triple and quadruple mutants in the dihydropteroate synthase and dihydrofolate reductase genes of Plasmodium falciparum parasites contrasts with the efficacy of sulfadoxine/pyrimethamine in reducing low birthweights and placental infection rates. In light of this discrepancy, emphasis on using molecular markers for monitoring efficacy of intermittent preventive treatment during pregnancy appears questionable. The World Health Organization recently proposed conducting in vivo studies in pregnant women to evaluate molecular markers for detecting resistance precociously. Other possible alternative strategies are considered.Keywords
This publication has 34 references indexed in Scilit:
- Burden of Malaria during Pregnancy at the Time of IPTp/SP Implementation in GabonThe American Journal of Tropical Medicine and Hygiene, 2010
- Molecular Correlates of High-Level Antifolate Resistance in Rwandan Children with Plasmodium falciparum MalariaAntimicrobial Agents and Chemotherapy, 2010
- Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatmentProceedings of the National Academy of Sciences, 2009
- Randomized Trial of Artesunate+Amodiaquine, Sulfadoxine-Pyrimethamine+Amodiaquine, Chlorproguanal-Dapsone and SP for Malaria in Pregnancy in TanzaniaPLOS ONE, 2009
- High Resistance of Plasmodium falciparum to Sulphadoxine/Pyrimethamine in Northern Tanzania and the Emergence of dhps Resistance Mutation at Codon 581PLOS ONE, 2009
- Effect of Sulfadoxine-Pyrimethamine Resistance on the Efficacy of Intermittent Preventive Therapy for Malaria Control During PregnancyJAMA, 2007
- Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'ZérékoréMalaria Journal, 2007
- Safety and Toxicity of Sulfadoxine/PyrimethamineDrug Safety, 2007
- Chloroquine‐Resistant MalariaThe Journal of Infectious Diseases, 2001
- Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in TanzaniaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1996